AN2 Therapeutics, Inc.'s total assets for Q1 2024 were $121.27M, a decrease of -12.60% from the previous quarter. ANTX total liabilities were $10.66M for the fiscal quarter, a -24.07% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.